Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Amauromine is a neutral antagonist of the cannabinoid (CB) receptor CB1 that is selective for CB1 (Ki = 178 nM; Kb = 66.6 nM) over CB2, with no activity at CB2 receptors at concentrations up to 10 µM.1 It is also an antagonist of GPR18 (IC50 = 3.74 µM).2 Amauromine has vasodilatory activity.3
WARNING This product is not for human or veterinary use.
1. Identification of a potent and selective cannabinoid CB1 receptor antagonist from Auxarthron reticulatum. ACS Med. Chem. Lett. 2(11), 866-869 (2011).
2. GPR18 inhibiting amauromine and the novel triterpene glycoside auxarthonoside from the sponge-
3. Structure of amauromine, a new alkaloid with vasodilating activity produced by Amauroascus. sp. Tetrahedron Lett. 25(41), 4673-4676 (1984).